Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicity
- 1.5k Downloads
To evaluate the impact of a mobile phone-based, remote monitoring, advanced symptom management system (ASyMS©) on the incidence, severity and distress of six chemotherapy-related symptoms (nausea, vomiting, fatigue, mucositis, hand–foot syndrome and diarrhoea) in patients with lung, breast or colorectal cancer.
A two group (intervention and control) by five time points (baseline, pre-cycle 2, pre-cycle 3, pre-cycle 4 and pre-cycle 5) randomised controlled trial.
Seven clinical sites in the UK; five specialist cancer centres and two local district hospitals.
One hundred and twelve people with breast, lung or colorectal cancer receiving outpatient chemotherapy.
A mobile phone-based, remote monitoring, advanced symptom management system (ASyMS©).
Main outcome measures
Chemotherapy-related morbidity of six common chemotherapy-related symptoms (nausea, vomiting, fatigue, mucositis, hand–foot syndrome and diarrhoea).
There were significantly higher reports of fatigue in the control group compared to the intervention group (odds ratio = 2.29, 95%CI = 1.04 to 5.05, P = 0.040) and reports of hand–foot syndrome were on average lower in the control group (odds ratio control/intervention = 0.39, 95%CI = 0.17 to 0.92, P = 0.031).
The study demonstrates that ASyMS© can support the management of symptoms in patients with lung, breast and colorectal cancer receiving chemotherapy.
KeywordsChemotherapy Symptoms Technology Assessment
- 1.Scottish Executive (2001) Cancer scenarios: an aid to planning cancer services in Scotland in the next decade. Available at http://www.scotland.gov.uk/Resource/Doc/158659/0043045.pdf
- 2.Department of Health (2007) Cancer reform strategy—executive summary.Google Scholar
- 3.The Scottish Government (2007) Better health, better care. Scottish Government, Edinburgh. Available at http://www.scotland.gov.uk/Topics/Health/Action-Plan
- 8.Chen-Hardee S, Chrischilles EA, Voelker MD, Brooks JM, Scott S, Link BK et al (2006) Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States). Cancer Causes Control 17(5):647–654 doi:10.1007/s10552-005-0502-4 PubMedCrossRefGoogle Scholar
- 10.National Institute for Health (2002) Management of cancer symptoms: pain, depression and fatigue. Available at http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1a.chapter.5
- 11.Cleeland CS, Cleeland LM, Dar R, Rinehardt LC (1986) Factors influencing physician management of cancer pain. Cancer 58(3):796–800 doi:10.1002/1097-0142(19860801)58:3<796::AID-CNCR2820580331>3.0.CO;2-# PubMedCrossRefGoogle Scholar
- 12.Scottish Executive Health Department (2005a) Delivering for Health Edinburgh. Scottish Executive Health Department, EdinburghGoogle Scholar
- 14.Scottish Executive Health Department (2005b) National service framework for Service Change Edinburgh. Scottish Executive Health Department, EdinburghGoogle Scholar
- 25.Brown V, Sitzia J, Richardson A, Hughes J, Hannon H, Oakley C (2001) The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy. Int J Nurs Stud 38(5):497–510 doi:10.1016/S0020-7489(00)00106-1 PubMedCrossRefGoogle Scholar
- 26.The National Cancer Institute (2003) The common toxicity adverse events criteria. National Cancer Institute, BethesdaGoogle Scholar
- 28.McCloone P (2004) Carstairs scores for Scottish postcode sectors from the 2001 Census. Public Health Research Unit, University of Glasgow, GlasgowGoogle Scholar
- 29.Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SA et al (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment study. Semin Hematol 3(2):4–12Google Scholar
- 34.Gibson F, Aldiss S, McCann L, Maguire R, Miller M, Kearney N (2007) Using a mobile phone based advanced symptom management system to monitor and manage chemotherapy related toxicity. Pediatric Blood and Cancer 49(4):408 (Abstract 0.035 oral). Proceedings of the 39th Annual Conference of the International Society of Paediatric Oncology (SIOP), Mumbai, IndiaGoogle Scholar
- 36.McCann L, Maguire R, Miller M, Kearney N (2008) Patients perceptions and experiences of using a mobile phone bases Advanced Symptom Management System (ASyMS©) to monitor and manage chemotherapy related toxicity. Eur J Cancer Care (Engl) (in press)Google Scholar
- 37.McCall K, Keen JN, Farrer K, Maguire R, McCann L, Johnston B, McGill M, Sage M, Kearney N (2008) Health professionals and patients perceptions of the use of a remote monitoring system (ASyMS©) in the recording and management of symptoms in patients receiving palliative care at home. Int J Palliat Nurs (in press)Google Scholar
- 38.Office for National Statistics (2006) Cancer statistics registrations: registrations of cancer diagnosed in 2004, England. Series MB1 no. 35. Office for National Statistics, LondonGoogle Scholar
- 39.ISD Online. Cancer incidence, mortality and survival data. http://www.isdscotland.org/cancer. Accessed 2007
- 40.Welsh Cancer Intelligence and Surveillance Unit (2007) Cancer incidence in Wales. Available at http://www.wales.nhs.uk/sites3/home.cfm?OrgID=242
- 41.Northern Ireland Cancer Registry. Cancer Incidence and Mortality. http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/#d.en.26094 Accessed 2007
- 43.Diggle PJ, Heagerty PJ, Liang KY, Zeger SL (2002) Analysis of longitudinal data, 2nd edn. Oxford University Press, OxfordGoogle Scholar